Enterprise Products Partners Investing Cash Flow increased by 69.1% to -$381.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.6%, from -$1.05B to -$381.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 26.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$572.00M | -$492.00M | -$414.00M | -$3.53B | -$336.00M | -$441.00M | -$645.00M | -$637.00M | -$765.00M | -$818.00M | -$977.00M | -$1.04B | -$1.24B | -$1.15B | -$2.00B | -$1.05B | -$1.27B | -$1.94B | -$1.24B | -$381.00M |
| QoQ Change | — | +14.0% | +15.9% | -753.1% | +90.5% | -31.3% | -46.3% | +1.2% | -20.1% | -6.9% | -19.4% | -6.2% | -19.7% | +7.3% | -73.6% | +47.6% | -21.7% | -51.9% | +36.2% | +69.1% |
| YoY Change | — | — | — | — | +41.3% | +10.4% | -55.8% | +82.0% | -127.7% | -85.5% | -51.5% | -63.0% | -62.5% | -40.8% | -104.7% | -0.9% | -2.5% | -68.0% | +38.3% | +63.6% |